Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
88.39
+2.43 (2.83%)
At close: Nov 21, 2024, 4:00 PM
88.30
-0.09 (-0.10%)
After-hours: Nov 21, 2024, 6:37 PM EST
Vaxcyte Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Cash & Equivalents | 1,050 | 397.45 | 834.66 | 68.99 | 386.2 | 58.98 | Upgrade
|
Short-Term Investments | 1,130 | 682.78 | 96.72 | 176.99 | - | - | Upgrade
|
Cash & Short-Term Investments | 2,180 | 1,080 | 931.38 | 245.97 | 386.2 | 58.98 | Upgrade
|
Cash Growth | 72.28% | 15.98% | 278.65% | -36.31% | 554.84% | -10.76% | Upgrade
|
Other Receivables | 17.87 | 3.61 | 3.88 | 1.2 | 0.3 | 0.2 | Upgrade
|
Receivables | 17.87 | 3.61 | 3.88 | 1.2 | 0.3 | 0.2 | Upgrade
|
Prepaid Expenses | 10.59 | 6.16 | 5.31 | 9.18 | 2.5 | 2.55 | Upgrade
|
Other Current Assets | 4.94 | 5.96 | 1.99 | - | - | - | Upgrade
|
Total Current Assets | 2,214 | 1,096 | 942.56 | 256.35 | 389 | 61.72 | Upgrade
|
Property, Plant & Equipment | 191.94 | 110.62 | 31.65 | 35.91 | 3.27 | 3.39 | Upgrade
|
Long-Term Investments | 1,093 | 162.68 | 26.55 | 27.12 | - | - | Upgrade
|
Long-Term Deferred Charges | - | - | - | 0.5 | 0.1 | - | Upgrade
|
Other Long-Term Assets | 61.36 | 38.67 | 5.43 | 4.46 | 0.45 | 0.58 | Upgrade
|
Total Assets | 3,560 | 1,408 | 1,006 | 324.34 | 392.83 | 65.7 | Upgrade
|
Accounts Payable | 18.22 | 14.59 | 9.8 | 6.76 | 29.79 | 3.38 | Upgrade
|
Accrued Expenses | 95.93 | 123.64 | 24.82 | 16.68 | 17.06 | 7.5 | Upgrade
|
Current Portion of Leases | 9.64 | 7.11 | 5.91 | 5.28 | - | 0.16 | Upgrade
|
Other Current Liabilities | - | - | - | - | 0.01 | 0.02 | Upgrade
|
Total Current Liabilities | 123.79 | 145.34 | 40.53 | 28.72 | 46.86 | 11.05 | Upgrade
|
Long-Term Leases | 18.32 | 22.11 | 12.03 | 11.51 | - | - | Upgrade
|
Other Long-Term Liabilities | - | - | 0.01 | 0.1 | 0.12 | 0.26 | Upgrade
|
Total Liabilities | 142.11 | 167.45 | 52.57 | 40.32 | 46.98 | 11.31 | Upgrade
|
Common Stock | 0.13 | 0.1 | 0.08 | 0.06 | 0.05 | 0.01 | Upgrade
|
Additional Paid-In Capital | 4,669 | 2,165 | 1,476 | 582.84 | 544.35 | 2.97 | Upgrade
|
Retained Earnings | -1,251 | -924.39 | -522.13 | -298.64 | -198.56 | -109.35 | Upgrade
|
Comprehensive Income & Other | 0.14 | 0.18 | -0.36 | -0.24 | - | - | Upgrade
|
Total Common Equity | 3,418 | 1,240 | 953.61 | 284.02 | 345.84 | -106.37 | Upgrade
|
Shareholders' Equity | 3,418 | 1,240 | 953.61 | 284.02 | 345.84 | 54.39 | Upgrade
|
Total Liabilities & Equity | 3,560 | 1,408 | 1,006 | 324.34 | 392.83 | 65.7 | Upgrade
|
Total Debt | 27.96 | 29.22 | 17.94 | 16.78 | - | 0.16 | Upgrade
|
Net Cash (Debt) | 2,153 | 1,051 | 913.44 | 229.19 | 386.2 | 58.82 | Upgrade
|
Net Cash Growth | 71.94% | 15.06% | 298.55% | -40.66% | 556.64% | -5.82% | Upgrade
|
Net Cash Per Share | 18.91 | 10.82 | 14.08 | 4.41 | 13.07 | 15.50 | Upgrade
|
Filing Date Shares Outstanding | 124.64 | 108.41 | 80.03 | 56.31 | 51.33 | 4.06 | Upgrade
|
Total Common Shares Outstanding | 124.43 | 95.36 | 79.47 | 53.03 | 51.07 | 4.06 | Upgrade
|
Working Capital | 2,090 | 950.62 | 902.03 | 227.63 | 342.14 | 50.67 | Upgrade
|
Book Value Per Share | 27.47 | 13.01 | 12.00 | 5.36 | 6.77 | -26.20 | Upgrade
|
Tangible Book Value | 3,418 | 1,240 | 953.61 | 284.02 | 345.84 | -106.37 | Upgrade
|
Tangible Book Value Per Share | 27.47 | 13.01 | 12.00 | 5.36 | 6.77 | -26.20 | Upgrade
|
Machinery | 49.33 | 35.62 | 15.12 | 11.5 | 5.25 | 3.8 | Upgrade
|
Construction In Progress | 123.27 | 51.82 | - | - | 0.22 | - | Upgrade
|
Leasehold Improvements | 4.06 | 1.46 | 1.35 | - | 1.9 | 1.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.